Galderma's efforts to expand the market for Nemluvio are bearing more fruit ... During the open-label extension phase of the study, Beyonttra demonstrated a relative risk reduction in deaths ...

Galderma today announced that the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency and Swissmedi ...

Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent hearing loss disorders, today ...